Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Ziv-aflibercept for Refractory Diabetic Macular Edema
TCTR20191130001Phase 3Terminated
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- May 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of aflibercept in diabetic macular edema (DME), sponsored by Faculty of Medicine, Khon Kaen University. Started May 2020; status: terminated.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on TCTR20191130001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191130001.